Bonus Biogroup (BONS) — Working Capital to Net Assets Ratio
Bonus Biogroup (BONS) has a Working Capital to Net Assets ratio of 216.1% as of December 2025. Working capital of ILA-12.24 Million (current assets of ILA1.75 Million minus current liabilities of ILA13.99 Million) is measured against net assets of ILA-5.66 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Bonus Biogroup (BONS) balance sheet quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Bonus Biogroup Working Capital to Net Assets (2008–2025)
This chart shows how Bonus Biogroup's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2008 to 2025. As of December 2025, the ratio stands at 216.1%, reflecting working capital of ILA-12.24 Million against net assets of ILA-5.66 Million ILA. Check tangible net worth ratio of Bonus Biogroup to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Bonus Biogroup (2008–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Bonus Biogroup from 2008 to 2025, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is Bonus Biogroup worth.
| Year | WC/NA Ratio | Working Capital (ILA) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 216.1% | ILA-12.24 Million | ILA-5.66 Million | ILA1.75 Million | ILA13.99 Million | ▲ +226.6 pp |
| 2024 | -10.4% | ILA-726.00K | ILA6.96 Million | ILA7.19 Million | ILA7.92 Million | ▼ -80.5 pp |
| 2023 | 70.1% | ILA20.53 Million | ILA29.30 Million | ILA26.44 Million | ILA5.91 Million | ▼ -13.0 pp |
| 2022 | 83.0% | ILA46.81 Million | ILA56.39 Million | ILA54.43 Million | ILA7.62 Million | ▼ -2.5 pp |
| 2021 | 85.6% | ILA72.23 Million | ILA84.43 Million | ILA81.00 Million | ILA8.77 Million | ▲ +84.4 pp |
| 2020 | 1.2% | ILA363.00K | ILA30.68 Million | ILA16.74 Million | ILA16.37 Million | ▼ -109.2 pp |
| 2019 | 110.4% | ILA-15.15 Million | ILA-13.72 Million | ILA308.00K | ILA15.46 Million | ▲ +4.6 pp |
| 2018 | 105.8% | ILA-3.36 Million | ILA-3.18 Million | ILA9.09 Million | ILA12.45 Million | ▼ -8.7 pp |
| 2017 | 114.5% | ILA-7.31 Million | ILA-6.38 Million | ILA4.65 Million | ILA11.96 Million | ▲ +3.4 pp |
| 2016 | 111.1% | ILA-8.18 Million | ILA-7.36 Million | ILA2.08 Million | ILA10.26 Million | ▼ -56.7 pp |
| 2015 | 167.8% | ILA-2.33 Million | ILA-1.39 Million | ILA4.81 Million | ILA7.14 Million | ▲ +290.2 pp |
| 2014 | -122.4% | ILA-739.00K | ILA604.00K | ILA3.18 Million | ILA3.92 Million | ▼ -199.0 pp |
| 2013 | 76.7% | ILA4.94 Million | ILA6.45 Million | ILA6.65 Million | ILA1.71 Million | ▲ +396.8 pp |
| 2011 | -320.1% | ILA2.82 Million | ILA-881.00K | ILA3.71 Million | ILA891.00K | ▼ -429.0 pp |
| 2010 | 108.9% | ILA-41.59 Million | ILA-38.19 Million | ILA2.67 Million | ILA44.26 Million | ▼ -306.3 pp |
| 2009 | 415.2% | ILA-38.95 Million | ILA-9.38 Million | ILA16.33 Million | ILA55.28 Million | ▲ +560.3 pp |
| 2008 | -145.1% | ILA-17.22 Million | ILA11.86 Million | ILA12.79 Million | ILA30.00 Million | — |